ADVFN - Advanced Financial Network.
HOME» NASDAQ » N » NUVA Stock Price » NUVA Stock News

Nuvasive Share News

 Nuvasive (mm) Stock Price
NUVA Stock Price
 Nuvasive (mm) Stock Chart
NUVA Stock Chart
 Nuvasive (mm) Stock News
NUVA Stock News
 Nuvasive (mm) Company Information
NUVA Company Information
 Nuvasive (mm) Stock Trades
NUVA Stock Trades

NuVasive Shares Plunge On Lowered Outlook, Shaky Market

By Jon Kamp Of DOW JONES NEWSWIRES Shares of NuVasive Inc. (NUVA) plunged Friday after the company indicated it is suddenly feeling more pressure in a weakened market for spinal devices, which is being squeezed by health insurers. Several analysts reduced their ratings on NuVasive, which lowered some forecasts for 2010 and 2011 late Thursday. That caught the market off guard because NuVasive cut projections only six weeks earlier at an analyst meeting. The company knew then the market had slowed, but said Thursday things have suddenly gotten worse. As the third quarter ended "it became apparent that achieving the revenue guidance that we issued mid-September, which at that time we believed was reasonable, was actually a challenge," Alex Lukianov, the company's chairman and chief executive, said on a conference call Thursday. A big issue is deceleration in procedural volumes, which in turn is mainly linked to "heightened pushback from insurers," Lukianov said. He said procedures were being cancelled at "an unprecedented rate." NuVasive shares recently traded down 28% to $26.33, and have touched the lowest point since early last year. Other, bigger companies such as Medtronic Inc. (MDT) and Stryker Corp. (SYK) reported some resistance from insurers this summer, and the issue isn't new. But Lukianov indicated NuVasive has seen more pressure very recently, with increased demands for preauthorization. Certain procedures--for cases where spinal fusion is used to treat lower back pain without pain radiating to other places--are getting outright denied, and there is a spillover effect on other procedures, he said. "What is new is that NuVasive has begun to feel the pinch as more and more of its surgeons are starting to see procedure cancellations and deferrals," said Raj Denhoy, a Jefferies & Co. analyst. He still has a buy rating on NuVasive shares, but several other analysts don't, following a rash of downgrades Friday. JPMorgan's Michael Weinstein went to underweight from overweight while noting that the spine market and NuVasive are "under attack." Among others, Cowen & Co.'s Dough Schenkel lowered his rating to neutral from outperform, saying the thesis behind a higher rating "is no longer defensible." "While challenges in the spine market are widely understood, it is surprising that the outlook would have to be cut so materially given that management just lowered guidance at their September 14th investor meeting," Schenkel said. -By Jon Kamp, Dow Jones Newswires; 617-654-6728;

Stock News for Nuvasive (NUVA)
01/15/201409:06:21U.S. Hot Stocks: Hot Stocks to Watch
11/15/201308:55:37Highbridge Capital Management 3Q 13F: Largest Eliminations
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Purchases
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Sales
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest -2-
11/14/201307:21:26GAMCO Asset Management Inc. 3Q 13F: Largest -2-
11/14/201307:21:26GAMCO Asset Management Inc. 3Q 13F: Largest Purchases
06/12/201307:13:48NuVasive to Raise Litigation Expense After Medtronic Royalty...
10/04/201213:16:23NuVasive Shares Plunge as Customers, Sales Defect to Competitors
06/28/201212:15:42Hospitals Surge, Insurers Slide as Health-Care Law is Upheld
01/27/201213:42:21Judge Affirms Rulings Denying Medtronic, NuVasive Motions
01/25/201216:34:24Court Denies Medtronic, NuVasive Motions Ahead of Hearing Thursday
05/04/201118:58:26NuVasive 1Q Earnings Jump; Sees Signs Of Stabilization In Spinal-Device...
04/27/201116:40:18J&J Gains Orthopedic Heft With Synthes But Faces Challenges
01/28/201116:41:27Insurer Clarifies Policy, Seen As Win For Spinal Device Makers
01/18/201117:50:48NuVasive Says Cigna, Humana Back Spine Procedure; Shares Rise
12/22/201017:15:14Medical Groups Take Issue With Insurers' Spine Surgery Rule
12/01/201012:17:16NuVasive CEO Backs Views Of Spinal-Market Pressure, Outlook

Nuvasive and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations